Clinical trial
Assessment of Coronary Artery Disease by Hybrid PET/CT
NCT00320931 · University of Maryland, Baltimore, Other · Terminated
Key facts
| NCT number | NCT00320931 |
|---|---|
| Title | Assessment of Coronary Artery Disease by Hybrid PET/CT |
| Official title | Assessment of Coronary Flow Reserve and CT Angiography By Hybrid PET/CT: Relation to Clinically Indicated SPECT Studies |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Collaborators | Astellas Pharma Inc Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Hybrid PET/CT |
| Enrollment | 30 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 3, 2006 |
| Last update posted | Jun 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: